AR and prostate carcinoma: We also confirmed the correlation between AL121790.1 and AR activity (Fig. 3c) and additionally performed AR chromatin immunoprecipitation sequencing (ChIP-seq) on the prostate cancer cell line LNCaP treated with R1881 (a synthetic testosterone analog).